14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $80.50 $93.35 Friday, 3rd May 2024 BMRN stock ended at $82.44. This is 1.62% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.01% from a day low at $82.32 to a day high of $84.80.
90 days $80.50 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Nov 05, 2021 $82.68 $84.84 $82.23 $83.92 1 452 827
Nov 04, 2021 $82.09 $83.80 $82.09 $83.37 1 429 247
Nov 03, 2021 $83.32 $84.24 $82.86 $83.48 1 381 071
Nov 02, 2021 $82.24 $83.10 $81.04 $83.09 1 647 316
Nov 01, 2021 $79.16 $82.08 $79.07 $82.05 1 855 148
Oct 29, 2021 $77.81 $79.99 $77.52 $79.23 2 090 190
Oct 28, 2021 $73.50 $78.52 $72.61 $78.20 4 823 588
Oct 27, 2021 $73.35 $73.41 $71.59 $71.72 1 556 062
Oct 26, 2021 $73.60 $74.05 $73.05 $73.42 1 666 067
Oct 25, 2021 $73.80 $74.15 $73.35 $73.51 1 509 276
Oct 22, 2021 $74.80 $74.80 $73.28 $73.74 1 018 594
Oct 21, 2021 $75.27 $75.86 $74.97 $75.08 703 224
Oct 20, 2021 $74.60 $75.89 $74.42 $75.15 1 061 718
Oct 19, 2021 $74.40 $75.50 $73.92 $74.14 1 505 161
Oct 18, 2021 $75.75 $75.81 $73.10 $73.92 1 688 695
Oct 15, 2021 $77.52 $77.99 $75.87 $75.89 1 516 829
Oct 14, 2021 $76.87 $78.37 $76.06 $77.52 1 672 010
Oct 13, 2021 $78.77 $79.42 $76.68 $76.82 1 353 614
Oct 12, 2021 $78.04 $79.37 $77.96 $78.63 1 413 991
Oct 11, 2021 $77.71 $79.32 $77.56 $77.90 797 848
Oct 08, 2021 $77.49 $78.48 $76.88 $77.83 1 154 892
Oct 07, 2021 $78.77 $79.49 $76.97 $77.14 902 747
Oct 06, 2021 $76.46 $78.71 $76.46 $77.87 1 010 972
Oct 05, 2021 $75.98 $76.94 $75.96 $76.73 641 728
Oct 04, 2021 $76.00 $77.03 $75.19 $75.88 962 677
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT